{"chebi_id":"71272","chebi_name":"saxagliptin","chebi_synonyms":["BMS 477118","BMS-477118","(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile","(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile"],"diffprof_id_observed":["MTBLS2406_0001_00000009","MTBLS4893_0003_00000003","MTBLS4980_0001_00000006","MTBLS5943_0002_00000001"],"diffprof_id_var_observed":["MTBLS4893_0003_00000003"],"inchikey":"QGJUIPDUBHWZPV-SGTAVMJGSA-N","inn_name":"saxagliptin","iupac_name":"(1<i>S</i>,3<i>S</i>,5<i>S</i>)-2-[(2<i>S</i>)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","num_study_observed":4,"reactome_ids":["R-HSA-2980736","R-HSA-381771","R-HSA-392499","R-HSA-400508"],"reactome_names":["Peptide hormone metabolism","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","Metabolism of proteins","Incretin synthesis, secretion, and inactivation"],"study_id_observed":["MTBLS2406","MTBLS4893","MTBLS4980","MTBLS5943"],"study_id_var_observed":["MTBLS4893"],"synonym_name":"(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile"}